Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia

(1) Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke is limited because of several contraindications. In routine clinical practice, patients with a recent stroke are typically not treated with rt-PA in case of a recurrent ischemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhard, Sarah, Kestner, Roxane-Isabelle, Armbrust, Moritz, Steinmetz, Helmuth, Foerch, Christian, Bohmann, Ferdinand O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225099/
https://www.ncbi.nlm.nih.gov/pubmed/35743425
http://dx.doi.org/10.3390/jcm11123343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225099/
https://www.ncbi.nlm.nih.gov/pubmed/35743425
http://dx.doi.org/10.3390/jcm11123343

Ejemplares similares